Compound ID | 3403
ADS024
Synonym(s): ART24
Class: Microbiome modulating agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Clostridioides difficile; indicated for C. difficile infection (CDI); neutralizes toxins produced by CDI |
| Description: | Live biotherapeutic product containing Bacillus velezensis |
| Institute where first reported: | Adiso Therapeutics |
| Year first mentioned: | 2022 |
| Highest developmental phase: | Phase 1 (NCT04891965) |
| Development status: | Active |
| External links: | |
| Citation: | https://www.nature.com/articles/s41598-022-13248-4 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.